date,title,source
Oct-18-18,"New Research Coverage Highlights Altair Engineering, Genomic Health, Seres Therapeutics, REV Group, MACOM Technology Solutions, and New Mountain Finance  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Oct-22-18,"Seres Therapeutics Announces Appointment of Kevin Horgan, M.D., as Chief Medical Officer",Business Wire
Nov-05-18,"Seres Therapeutics to Host Third Quarter 2018 Financial Results and Operational Progress Conference Call and Webcast on November 8, 2018",Business Wire
Nov-08-18,"Seres Therapeutics (MCRB) Reports Q3 Loss, Misses Revenue Estimates",Zacks
Nov-08-18,Seres Therapeutics Reports Third Quarter Financial Results and Provides Operational Updates,Business Wire
Nov-09-18,Seres Therapeutics to Present at the Stifel 2018 Healthcare Conference,Business Wire
Nov-19-18,Edited Transcript of MCRB earnings conference call or presentation 8-Nov-18 1:30pm GMT,Thomson Reuters StreetEvents
Nov-28-18,"Research Report Identifies OraSure Technologies, Sierra Wireless, Seres Therapeutics, Lydall, ChromaDex, and Capricor Therapeutics with Renewed Outlook  Fundamental Analysis, Calculating Forward Movement",GlobeNewswire
Jan-03-19,Seres Therapeutics Announces Initiation of SER-287 Phase 2B ECO-RESET Clinical Study for Ulcerative Colitis,Business Wire
Jan-04-19,"Does Seres Therapeutics, Inc.s (NASDAQ:MCRB) CEO Salary Compare Well With Others?",Simply Wall St.
Jan-15-19,Seres Therapeutics Announces Chief Executive Officer Transition,Business Wire
Feb-07-19,Seres Therapeutics Announces Corporate Changes to Focus on Advancing Clinical Assets,Business Wire
Mar-04-19,"Seres Therapeutics to Host Fourth Quarter and Full Year 2018 Financial Results and Operational Progress Conference Call and Webcast on March 6, 2019",Business Wire
Mar-05-19,Seres Therapeutics to Present at Three Upcoming March Conferences,Business Wire
Mar-06-19,Seres Therapeutics Inc (MCRB) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Mar-06-19,Seres Therapeutics Reports Fourth Quarter and Full Year Financial Results and Provides Operational Updates,Business Wire
Mar-11-19,Seres Therapeutics Options Volume Peaks After AstraZeneca News,Schaeffer's Investment Research
Mar-11-19,Here's Why Seres Therapeutics Stock Soared Today,Motley Fool
Mar-11-19,Seres teams up with AstraZeneca to explore microbiome benefits in cancer treatment,American City Business Journals
Mar-11-19,Seres Therapeutics Announces Microbiome Immuno-Oncology Focused Collaboration with AstraZeneca,Business Wire
Mar-13-19,Seres Therapeutics (MCRB) in Focus: Stock Moves 6.7% Higher,Zacks
Mar-13-19,Edited Transcript of MCRB earnings conference call or presentation 6-Mar-19 1:30pm GMT,Thomson Reuters StreetEvents
Mar-22-19,Edited Transcript of MCRB earnings conference call or presentation 6-Mar-19 1:30pm GMT,Thomson Reuters StreetEvents
Apr-02-19,Seres Therapeutics Presents New Preclinical Data Supporting the Development of SER-401 for Immuno-Oncology at the 2019 American Association for Cancer Research Annual Meeting,Business Wire
Apr-25-19,Here's Why The Bacteria In Your Gut Could Be A Blockbuster Opportunity,Investor's Business Daily
Apr-26-19,Gut Check: The Bacteria In Your Intestines Could Help Cure Cancer,Investor's Business Daily
Apr-29-19,"Seres Therapeutics to Host First Quarter 2019 Financial Results and Operational Progress Conference Call and Webcast on May 2, 2019",Business Wire
May-02-19,"Seres Therapeutics (MCRB) Reports Q1 Loss, Lags Revenue Estimates",Zacks
May-02-19,Seres Therapeutics: 1Q Earnings Snapshot,Associated Press
May-02-19,Seres Therapeutics Reports First Quarter Financial Results and Provides Clinical Pipeline Progress Update,Business Wire
May-02-19,"Seres Therapeutics, Inc. to Host Earnings Call",ACCESSWIRE
May-08-19,Edited Transcript of MCRB earnings conference call or presentation 2-May-19 12:30pm GMT,Thomson Reuters StreetEvents
May-29-19,Seres Therapeutics to Present at the Jefferies 2019 Healthcare Conference,Business Wire
Jun-12-19,"Seres Therapeutics, Inc. Announces Proposed Public Offering of Common Stock",Business Wire
Jun-13-19,"Seres Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock",Business Wire
Jun-13-19,"The Daily Biotech Pulse: Savara Slumps On Flunked Trial, NuCana Takes Off, Tetraphase Downsizes",Benzinga
Jun-17-19,Microbiome Therapeutics Innovation Group Statement on FDA Safety Alert Regarding Use of Fecal Microbiota for Transplantation and Risk of Serious Adverse Reactions Due to Transmission of Multi-Drug Resistant Organisms,PR Newswire
Jun-19-19,Seres Therapeutics Issues Statement Regarding U.S. Food and Drug Administration Safety Alert Related to Use of Fecal Microbiota Transplantation,Business Wire
